Walgreens Boots Alliance, Inc.WBA

時価総額

$103.6億

PER

小売薬局と医療サービスの米国最大手、従業員約31.2万人在籍。店舗調剤、バリューベースのプライマリケアや在宅医療、スペシャリティ薬局を展開。2021年にVillageMDを約52億ドルで買収、2022年にSummitを買収。米国・英国・欧州で展開。

概要財務

サマリーテーブルに戻る

	2015年 8月31日	2016年 8月31日	2017年 8月31日	2018年 8月31日	2019年 8月31日	2020年 8月31日	2021年 8月31日	2022年 8月31日	2023年 8月31日	2024年 8月31日
Net earnings (loss)	4,279	4,191	4,101	5,031	3,962	424	2,512	4,065	-3,528	-15,448
Depreciation and amortization	1,742	1,718	1,654	1,770	2,038	1,927	1,973	1,990	2,257	2,459
Deferred income taxes	-32	-442	-434	-322	100	-43	233	-366	-2,371	917
Stock compensation expense	109	115	91	130	119	137	155	391	385	182
Earnings from equity method investments	-	44	-	-	-	382	-498	468	286	230
Goodwill and Intangible Asset Impairment	-	-	-	-	-	-	-	834	1,293	14,370
Gain on previously held investment interests	-	-	-	-	-	-	-	2,576	-	-
Gain on sale of equity method investments	-	-	-	-	-	-	321	559	1,855	1,520
Impairment of equity method investments and investments in equity and debt securities	-	-	-	-	-	-	-	-	-	364
Gain on sale-leaseback transactions	-	-	-	-	-	-	-	-	925	295
Loss (gain) on variable prepaid forward contracts	-	-	-	-	-	-	-	-	-	-946
Other	685	-261	-11	177	-	-464	64	146	157	242
Accounts receivable, net	338	-115	153	391	789	-163	1,451	-808	-72	464
Inventories	-719	644	-98	-331	-141	-63	-165	433	-287	31
Other current assets	-22	-66	-	22	112	31	46	72	188	-82
Trade accounts payable	268	1,572	1,690	1,323	954	-25	842	244	1,243	1,409
Accrued expenses and other liabilities	170	313	-128	281	-374	1,008	1,046	-138	-561	-536
Income taxes	-335	202	44	694	-406	-221	160	-51	441	30
Accrued litigation obligations	-	-	-	-	-	-	-	-	6,378	-333
Other non-current assets and liabilities	-11	58	67	-275	-154	-16	-288	137	-228	-643
Net cash provided by operating activities	-	-	-	8,265	5,594	5,484	5,555	3,899	2,258	1,018
Additions to property, plant and equipment	1,251	1,325	1,351	1,367	1,702	1,374	1,379	1,734	2,117	1,381
Proceeds from sale-leaseback transactions	-	-	-	-	-	724	856	1,308	1,767	898
Proceeds from sale of other assets	184	155	59	655	117	90	453	1,334	4,495	2,860
Business, investment and asset acquisitions, net of cash acquired	-	-	-	-	-	-	-	-2,189	-7,313	-402
Other	59	-5	-93	-4	-16	19	-46	-216	-75	97
Net cash provided by (used for) investing activities	-	-	-	-5,501	-2,307	-1,297	4,072	-1,064	-3,094	1,878
Proceeds from (Repayments of) Short-Term Debt	-	29	33	586	536	-161	-909	-11	-1	-2
Proceeds from debt	-	-	-	-	-	20,367	12,726	11,958	6,276	31,365
Payments of debt	-	791	6,196	4,890	10,461	21,414	15,257	8,360	8,978	30,474
Acquisition of non-controlling interests	-	-	-	-	-	-	-	2,108	1,316	-
Proceeds from Noncontrolling Interests	-	-	-	-	-	-	-	-	2,725	-
Proceeds from variable prepaid forwards	-	-	-	-	-	-	-	-	2,568	424
Treasury stock purchases	1,226	1,152	5,220	5,228	4,160	1,589	110	187	150	69
Cash dividends paid	1,384	1,563	1,723	1,739	1,643	1,747	1,617	1,659	1,659	1,260
Early debt extinguishment	-	-	-	-	-	-	3,687	1,591	-	318
Other	-395	-143	-45	-98	75	-157	-241	432	-396	-203
Net cash used for financing activities	-	-	-	-5,295	-3,047	-4,647	-9,036	-1,499	-887	-538
Effect of exchange rate changes on cash, cash equivalents, marketable securities and restricted cash	-	-	-	-	-9	-1	-66	-47	20	4
Net increase (decrease) in cash, cash equivalents, marketable securities and restricted cash	-	-	-	-	232	-460	525	1,288	-1,702	2,362